Eric Ka Wai Hui
Armagen, USA
Biography
Eric Ka Wai Hui is a Principal Investigator at ArmaGen, Inc., a biotech company focused in the development of biotherapeutics for the brain. Dr. Hui joined ArmaGen in 2008 following 10 years of academic experience in molecular biology of neuroscience. His responsibilities have been instrumental in the development of ArmaGen’s extensive product pipeline, including potential biotherapeutic treatments for mucopolysaccharidosis, stroke, Alzheimer’s disease and Parkinson’s disease. Dr. Hui has a Ph.D. in Microbiology and Immunology, and he has published numerous papers in his field.